MYX 0.47% $4.26 mayne pharma group limited

Bell Potter downgrade MYX from hold to sell, target 77 cents

  1. 709 Posts.
    lightbulb Created with Sketch. 95
    as reported by Dow Jones Newswire yesterday morning:

    Mayne Pharma Price Target Raised 4.1% to A$0.77/Share by Bell Potter


    Mayne Pharma Downgraded to Sell from Hold by Bell Potter



    So, it seems that the market valuation has shifted to 77 cents, and Bell Potter thinks we should profit take.
 
watchlist Created with Sketch. Add MYX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.